NPRA approves six-month shelf life extension for Coronavac, Comirnaty Covid-19 vaccines

PUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved an extension for the shelf life of SinoVac's CoronaVac and Pfizer-BioNTech's Comirnaty Covid-19 vaccines, says Health director-general Tan Sri Dr Noor Hisham Abdullah.

He said NPRA had approved the respective applications from Pharmaniaga Lifescience Sdn Bhd and Pfizer (Malaysia) Sdn Bhd.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Subscribe

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Subscribe

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only

Subscribe
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Expiry date , Shelf life , SinoVac , CoronaVac , Pfizer , BioNTech , Comirnaty , Covid-19 , Vaccine , Health Ministry , Noor Hisham Abdullah

   

Report it to us.

Next In Nation
Ipoh Railway Station roof leaks to be fixed by February, exco
Organised crime trial of 22 GISB leaders transferred to Shah Alam High Court
Two fishermen arrive home after six-day ordeal in open seas
PBS and Sabah STAR to co-host Christmas open house
Sabah to host inaugural Asean tourism networking event in June
NUMed goes green for a brighter, healthier world
GISB leaders under heavy police guard at Selayang court
Man loses RM325,811 to fake investment scheme in JB
Mother dies, husband and sons injured after car ends up in ditch in KK
Cops bust drug syndicate in JB, seize RM200,000 of illegal substances

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.